CLEOCIN

Pre-Launch

clindamycin palmitate hydrochloride

ANDAORALFOR SOLUTION

Lifecycle

Pre-Launch

Data completeness

3/8 — Basic

CLEOCIN (clindamycin palmitate hydrochloride) by Pfizer is clinical pharmacology mechanism of action clindamycin is an antibacterial drug (see). Approved for the treatment of serious infections caused by susceptible anaerobic bacteria, the treatment of serious infections due to susceptible strains of streptococci, pneumococci and 7 more indications.

Drug data last refreshed 1mo ago

$0.0BPart D

Mechanism of Action

CLINICAL PHARMACOLOGY Mechanism of Action Clindamycin is an antibacterial drug (See). Pharmacokinetics Systemic absorption of clindamycin was estimated following a once-a-day intravaginal dose of one clindamycin phosphate vaginal suppository (equivalent to 100 mg clindamycin) administered to 11…

Indications (10)

Worked on CLEOCIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.